130 results
Page 2 of 7
8-K
EX-99.1
db2pvpxph
15 Aug 22
Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update
8:05am
8-K
EX-10.1
34jryjcb
21 Jun 22
Departure of Directors or Certain Officers
7:31am
8-K
EX-99.1
b0y602b62
9 Jun 22
Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
8:08am
8-K
EX-99.1
0hpnbvabxhuc4c050k1
26 May 22
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting
5:06pm
8-K
EX-99.1
tqpzli yj5ka7ggt
13 May 22
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
8:03am
PRE 14A
ozbcb3hjfq1aotco1n5
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-99.1
vdnc8
29 Mar 22
Tempest Reports Year End 2021 Financial Results and Provides Corporate Highlights
4:41pm
8-K
EX-99.1
m98a6 tpobb
10 Nov 21
Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
3:54pm
8-K
EX-99.1
ngl9y
12 Aug 21
Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights
4:23pm
8-K
grh06
16 Jul 21
Other Events
4:31pm
8-K
EX-99.2
ra93iyqkc3z24
16 Jul 21
Other Events
4:31pm
8-K
EX-99.1
m4mfus 7ji7zt2gq5gl
16 Jul 21
Other Events
4:31pm
S-8
EX-10.1
9bkx39phobyui3p g8e
7 Jul 21
Registration of securities for employees
12:00am
S-8
EX-10.2
k4od2v rof
7 Jul 21
Registration of securities for employees
12:00am